Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Head & Neck 1 Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 63 Specimen Handling 58 pembrolizumab 40 enzalutamide 38 Nivolumab 32 Gemcitabine 30 Docetaxel 28 Biopsy 25 Prednisone 23 Abiraterone Acetate 21 apalutamide 20 Androgen Antagonists 19 Radiosurgery 18 Cisplatin 18 darolutamide 16 cabozantinib 16 abiraterone 16 Radiotherapy 16 enfortumab vedotin 15 Radiation 14 Ipilimumab 13 belzutifan 12 Pluvicto 12 Mitomycin 12 olaparib 11 erdafitinib 11 durvalumab 11 atezolizumab 11 X-Rays 10 Standard of Care 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Atorvastatin × Genitourinary × 30 days × Clear all

NCT03819101 2026-05-06

PEACE-4

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡